Biotech
Sunbird Bio
Sunbird Bio raises $85M Series B at $450M valuation
Emeryville, CAOctober 15, 20241 min read
Total Raised
$85M
Valuation
$450M
Latest Round
Series B
Employees
120+
Sunbird Bio: Series B Funding Round
Sunbird Bio has successfully raised $85M in Series B funding, reaching a valuation of $450M.
Company Overview
Molecular diagnostics technology
Funding Details
The Series B round was led by Deerfield Management, with participation from Casdin Capital.
Company Information
- Headquarters: Emeryville, CA
- Founded: 2018
- Employees: 120+
- Category: Biotech
Investment
Sunbird Bio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Deerfield Management: Verified investor in Series B
- Casdin Capital: Verified investor in Series B
Company Info
Headquarters
Emeryville, CA
Founded
2018
Team Size
120+
Last Round
$85M(Oct 2024)
Investors (2)
D
Deerfield ManagementLeadLead Investor
Verified investor in Series B
C
Casdin CapitalInvestor
Verified investor in Series B
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free